DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2016$3,170,000
-68.6%
1,315,5510.0%0.14%
-67.0%
Q4 2015$10,090,000
+45.0%
1,315,5510.0%0.41%
+52.0%
Q3 2015$6,959,000
-41.0%
1,315,5510.0%0.27%
-31.6%
Q2 2015$11,800,000
+36.8%
1,315,551
-3.6%
0.39%
+40.9%
Q1 2015$8,627,000
+239.0%
1,365,000
+458.2%
0.28%
+168.3%
Q1 2014$2,545,000244,5240.10%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2023
NameSharesValueWeighting ↓
FNY Managed Accounts LLC 75,000$35,258,0000.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 696,455$327,0000.02%
Klingman & Associates, LLC 10,000$5,0000.00%
BLUESTEIN R H & CO LLC 76,500$36,0000.00%
OPPENHEIMER & CO INC 73,500$34,0000.00%
Renaissance Technologies 774,603$364,0000.00%
Walleye Trading LLC 6$00.00%
Bank of New York Mellon Corp 16,660$8,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,071$5,0000.00%
SIMPLEX TRADING, LLC 200$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders